Vanderbilt General Clinical Research Center Archives
Sep. 4, 2019—A novel treatment for Prader-Willi syndrome, one of the most common genetic causes of obesity, may improve the insatiable hunger that patients with the disorder experience.
Apr. 19, 2018—David Robertson, MD, internationally known for his groundbreaking work in defining and treating often-debilitating neurological disorders of blood pressure regulation, will be honored with a two-day symposium May 3-4 at Langford Auditorium.
Nov. 30, 2017—When David Robertson, MD, sorted through 39 years’ worth of textbooks, journals and framed photographs in Vanderbilt University Medical Center’s (VUMC) Clinical Research Center (CRC) recently as he prepared for retirement, the memory that brought him to tears was a 30-year-old embroidery piece by his daughter, Rose Robertson Pink.
Nov. 30, 2017—Kevin Niswender, MD, PhD, whose work has helped advance understanding of the neural underpinnings of obesity and metabolic syndrome, has been named director of the Clinical Research Center (CRC) at Vanderbilt University Medical Center (VUMC).
Nov. 6, 2014—A nationwide research group headed by Vanderbilt University’s David Robertson, M.D., has received another round of funding from the federal government to continue studies of rare neurodegenerative diseases and disorders affecting blood pressure.
Apr. 13, 2012—Vanderbilt’s idiopathic pulmonary fibrosis research group is embarking on a study to determine the prevalence of sleep apnea in people with other interstitial lung diseases.